Sana Biotechnology annual operating expenses
2019
2020
2021
2022
2023
2024
2025
Sana Biotechnology Operating Expenses Growth & History (SANA)
Sana Biotechnology's operating expenses was $250.3M for fiscal 2025.
View full Sana Biotechnology company overviewSana Biotechnology annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $250.3M | −$22.4M | −8.21% |
| 2024 | 2024-12-31 | $272.7M | −$20.4M | −6.97% |
| 2023 | 2023-12-31 | $293.1M | $20.6M | +7.55% |
| 2022 | 2022-12-31 | $272.6M | −$84.3M | −23.63% |
| 2021 | 2021-12-31 | $356.9M | $70.8M | +24.73% |
| 2020 | 2020-12-31 | $286.1M | $145.0M | +102.72% |
| 2019 | 2019-12-31 | $141.2M | — | — |
Sana Biotechnology quarterly operating expenses
Q1.20
Q3.20
Q1.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $65.4M | −$29.6M | −31.12% |
| Q1 2026 | 2026-03-31 | $48.6M | −$2.0M | −3.98% |
| Q4 2025 | 2025-12-31 | $61.2M | $10.3M | +20.31% |
| Q3 2025 | 2025-09-30 | $43.5M | −$18.2M | −29.54% |
| Q2 2025 | 2025-06-30 | $95.0M | $45.6M | +92.37% |
| Q1 2025 | 2025-03-31 | $50.6M | −$60.1M | −54.27% |
| Q4 2024 | 2024-12-31 | $50.9M | −$39.8M | −43.87% |
| Q3 2024 | 2024-09-30 | $61.8M | $59.6M | +2731.77% |
| Q2 2024 | 2024-06-30 | $49.4M | −$66.9M | −57.54% |
| Q1 2024 | 2024-03-31 | $110.7M | $26.7M | +31.73% |
| Q4 2023 | 2023-12-31 | $90.6M | $8.8M | +10.80% |
| Q3 2023 | 2023-09-30 | $2.2M | −$84.0M | −97.47% |
| Q2 2023 | 2023-06-30 | $116.3M | $43.4M | +59.51% |
| Q1 2023 | 2023-03-31 | $84.1M | $52.4M | +165.27% |
| Q4 2022 | 2022-12-31 | $81.8M | — | — |
| Q3 2022 | 2022-09-30 | $86.2M | $2.8M | +3.30% |
| Q2 2022 | 2022-06-30 | $72.9M | — | — |
| Q1 2022 | 2022-03-31 | $31.7M | −$149.1M | −82.47% |
| Q3 2021 | 2021-09-30 | $83.4M | $31.8M | +61.55% |
| Q1 2021 | 2021-03-31 | $180.8M | $147.5M | +443.20% |
| Q3 2020 | 2020-09-30 | $51.6M | — | — |
| Q1 2020 | 2020-03-31 | $33.3M | — | — |
Sana Biotechnology operating expenses trends
Over the last five fiscal years, Sana Biotechnology's operating expenses decreased from $286.1M to $250.3M, a change of −$35.8M. The latest reported quarter, Q2 2026, shows $65.4M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sana Biotechnology source filings ↗